the reduction of attained height and the 'early programming' of CHD.
The hypothesis of a genetic contribution to the relationship between height and CHD is supported by the results of the European Atherosclerosis Research Study (EARS) which showed that young adults whose father had had a premature myocardial infarction were shorter in height than age-and sexmatched controls, this difference being independent of father's educational attainment. 12 In the EARS study, the most discriminant factors between subjects with and without a paternal history of CHD were low density lipoprotein cholesterol (LDL-C), apolipoprotein (apo) B, and triglycerides levels, 13 and these factors negatively correlated with height more strongly in cases than in control subjects. 12 These findings suggested that common transmissible factors jointly influencing height and lipids might be involved in the familial predisposition to CHD.
A genetic contribution to the relationship between height and cardiovascular risk factors would imply a clustering of these traits within families. Height 14, 15 and cardiovascular risk factors such as lipid and BP levels [16] [17] [18] [19] are known to be highly heritable, but little is known about their possible familial clustering. The present study was aimed at investigating whether cardiovascular risk factors shared a common familial determinism with height. For this purpose, a series of bivariate familial correlation analyses between height and each of the risk factors was performed, in order to test the hypothesis of a co-variation of the traits within families. Significant cross-trait correlations between biological relatives (e.g. correlation between the height of a sib and the cholesterol level of the other sib), but not between spouses, would suggest that common transmissible factors are involved in the aetiology of both traits. Conversely, cross-trait correlations of similar magnitude among all family members would rather suggest the influence of shared lifestyle factors. 20, 21 This study was performed in the STANISLAS cohort composed of 865 healthy nuclear families.
Methods
A detailed description of the STANISLAS cohort has been given elsewhere. 22 In brief, families selected from the general population living in the eastern part of France were invited for a free health check-up at the Center for Preventive Medicine in Vandoeuvre-lès-Nancy between October 1993 and June 1994. The inclusion criteria were the presence of two parents and at least two biological children aged ജ8 years, the European origin of parents and grandparents, and the absence of acute or serious chronic disease. All family members were examined on the same day. All families provided written informed consent. Weight (to the nearest 100 g) and height (to the nearest 0.1 cm) were measured in subjects not wearing shoes or clothes. Two trained nurses measured BP with subjects in the supine position, after a 10-minute rest, on the right arm with a mercury sphygmomanometer and appropriately sized cuff, using the first and the fifth phases of the Korotkoff sounds. The average of two BP measurements (5-minute intervals) was used. In children, Tanner stage of sexual development was recorded by a physician based on a scale ranging from 2 to 10, as hairiness and external genitals scales were added, where stage 2 is pre-pubertal and stage 10 post-pubertal status.
Fasting blood samples were drawn after at least an 8-hour overnight fast. Serum levels of total cholesterol (total-C), high density lipoprotein cholesterol (HDL-C), and triglycerides were determined by routine clinical chemistry procedures. Values of LDL-C were calculated using the Friedewald's formula: 23 Familial correlation analyses were performed by use of the Estimating Equations (EE) technique extended to a bivariate phenotype as previously described. 21 Three kinds of correlations are estimated by this method: familial intra-trait correlations (e.g. correlations of height between family members), withinindividual cross-trait correlations (e.g. correlations between height and total-C in any class of relatives), and familial crosstrait correlations (e.g. correlations between height of an individual and total-C of his/her relative). Within-individual intra-trait correlations were estimated in the four classes of relatives (fathers, mothers, sons, and daughters) and familial intra-trait and cross-trait correlations were estimated in the four types of pairs of relatives (spouses, father-offspring, motheroffspring, and sib-sib). A Gaussian working correlation matrix was used in all analyses. Hypothesis testing was performed by use of the generalized Wald test statistics. 21 For example, testing the equality between three correlations (father-offspring, mother-offspring, and sib-sib) was achieved by using a Wald statistic which follows, under the null hypothesis, a χ 2 -distribution with 2 d.f. Familial cross-trait correlations were estimated assuming a 'symmetric' model which specified, for example, that the correlation between father's height and offspring's total-C was identical to the correlation between father's total-C and offspring's height. The validity of this hypothesis had been first tested for each pair of traits by comparing a general model with a restricted model assuming symmetry (χ 2 with 4 d.f.) and was never rejected. The strategy for testing the hypothesis of a common transmissible component influencing the association between height and any cardiovascular trait was (1) to test the homogeneity of the father-offspring, motheroffspring, and sib-sib cross-trait correlations (χ 2 with 2 d.f.), and (2) to compare the spouse correlation to the common correlation between biological relatives (assuming equality between the three aforementioned correlations).
In all analyses, height, lipids, and BP levels were first adjusted for age in all subjects, and Tanner stage in offspring. In a second step, lipids and BP levels were additionally adjusted for weight, oral contraception, and father's occupational level (lower versus others). All adjustments were performed within the EE regression model, separately in each class of relatives, hence implicitly controlling for gender effects. Parents taking lipid-lowering (n = 71) or anti-hypertensive (n = 39) medications were excluded from analyses on lipid or BP variables, respectively. The triglyceride distribution was log-transformed to remove positive skewness.
A P-value Ͻ 0.05 was considered as significant.
Results
Characteristics of the study population are given in Table 1 . The mean age of parents was approximately 40 years. The offspring age ranged from 8 to 20 years, with a mean age of almost 14 years. Nearly 25% of children had ended puberty, this proportion being similar in sons and daughters even though girls were on average more advanced in sexual maturation than boys. Only a small proportion of parents were taking lipidlowering or antihypertensive medications. As expected, for all biochemical parameters except HDL-C, fathers had higher mean levels than mothers. In offspring, differences between genders were less marked and generally in the opposite direction to parents, except BP levels which were higher in sons than in daughters.
Within-individual cross-trait correlations between height and cardiovascular risk factors
When adjusted for age and Tanner stage only, within-individual correlations between height and cardiovascular risk factors were generally weak, except for moderate positive correlations between height and BP levels in offspring (Table 2 ). However, after further adjustment for weight, oral contraception, and father's occupational level, height negatively correlated with total-C, LDL-C, and triglycerides in both parents and children, whereas it positively correlated with HDL-C only in parents (Table 2) . By contrast, further adjustment on these covariates markedly weakened the correlation between height and BP levels in offspring, whereas it revealed a negative correlation in fathers ( Table 2 ). The mean levels of adjusted lipids and BP variables according to quartiles of height in each class of relatives are shown in Figure 1 . Since sexual maturation strongly influences both height and cardiovascular factors, we further examined the correlations HEIGHT AND CARDIOVASCULAR RISK FACTORS 609 * P Ͻ 0.05; ** P Ͻ 0.01; *** P Ͻ 0.001.
within different groups of Tanner stage (ഛ3, 4-9, and 10). These correlations are shown for HDL-C, LDL-C, and systolic BP in Figure 2 . For total-C and triglycerides, the pattern was similar to that observed for LDL-C. For HDL-C, the correlation with height markedly increased with Tanner stage in male offspring, to reach at the end of puberty the value observed in adults. A similar trend, although weaker, was observed in females. Conversely, for LDL-C, the correlation with height did not vary with Tanner stage and was at any period of similar magnitude to the value estimated in parents, indicating little influence of sexual maturation on the LDL-C/height association. For systolic BP, the positive correlation with height was mainly observed in the youngest children and markedly weakened with sexual maturation.
Familial intra-trait correlations for height and cardiovascular risk factors
There was a strong resemblance for height between biological relatives, which was of similar magnitude between parents and offspring, and between sibs ( Table 3) . As expected in cases of likely assortative mating, spouses also resembled each other for height, although the correlation was much weaker than among biological relatives. Lipid levels also exhibited a strong familial resemblance (Table 3) . Total-C and LDL-C levels did not correlate between spouses, unlike HDL-C and triglycerides levels for which a shared environmental influence was suggested by the significant spouse correlation. The familial resemblance for BP traits was noticeably lower than for lipid variables. Adjustment for weight, oral contraception, and father's occupational level hardly modified the familial correlations for any of the traits considered.
Familial cross-trait correlations between height and cardiovascular risk factors
Given the within-individual relationship between height and cardiovascular risk factors on the one hand, and the strong familial resemblance for all these traits on the other hand, the next step was to investigate whether height shared a common familial component with some of the risk factors. This was done by estimating the familial cross-trait correlations between height and each cardiovascular risk factor (Table 4) . Age-and Tanneradjusted correlations were generally weak, but further adjustment for weight, oral contraception, and father's occupational level tended to increase the correlations of height with lipids, Figure 1 Mean of lipid and blood pressure (BP) levels according to quartiles of height among the different classes of relatives (height was adjusted for age and, in offspring, for Tanner stage; lipid and BP levels were additionally adjusted for weight, oral contraception, and father's occupational level)
whereas it decreased those with BP levels, as already observed for the within-individual cross-trait correlations. We next focused on fully adjusted correlations to further examine the pattern of familial cross-trait correlations. We first tested the homogeneity of correlations between the different classes of biological relatives (father-offspring, mother-offspring, and sib-sib). For all lipids, the cross-trait correlations were not significantly different among the three classes of biological relatives (P Ͼ 0.50 for the test of homogeneity of correlations for any of the traits). The common cross-trait correlation among biological relatives was estimated as -0.03 (P = 0.05) for total-C, -0.04 (P Ͻ 0.05) for LDL-C, +0.05 (P Ͻ 0.01) for HDL-C, and -0.08 (P Ͻ 0.001) for triglycerides. This common correlation significantly differed from the spouse correlation for total-C and LDL-C (P Ͻ 0.05), but not for triglycerides (P = 0.07) nor for HDL-C (P Ͼ 0.50). No significant familial cross-trait correlations between height and BP levels were observed (Table 4) .
Discussion
This study, based on a large sample of families volunteering for a free health check-up, confirmed that a short stature was associated with an unfavorable cardiovascular profile. The negative relationship of total-C, LDL-C, and triglycerides to height was observed both in parents and offspring and was of the same order of magnitude across generations. Moreover, in offspring, sexual maturation appeared to have little influence on the magnitude of these correlations despite the profound modifications of lipid levels induced by growth and puberty. 24, 25 By contrast, HDL-C was positively related to height only in adults, while no association was observed in the sample of offspring considered as a whole. However, unlike LDL-C, the magnitude of the correlation of HDL-C with height markedly increased with Tanner stage, to reach after puberty values similar to those observed in parents. Low density lipoprotein cholesterol levels have been shown to better track from childhood to adulthood than do HDL-C levels 24, 26 suggesting that additional sources of variability might affect HDL-C levels, especially during the course of puberty where a change in central pattern of body fat occurs. 27 The pattern of familial cross-trait correlations for LDL-C, with significant correlations between biological relatives and no correlation between spouses, suggested that transmissible factors might partly explain the negative association of this trait with height. A very similar pattern of cross-trait correlations was observed for apoB levels in the same cohort (data not shown). Even though statistically significant, the magnitude of the crosstrait correlation between biological relatives was weak, as might have been anticipated from the moderate within-individual correlation between height and LDL-C in this population of HEIGHT AND CARDIOVASCULAR RISK FACTORS 611 Figure 2 Within-individual cross-trait correlation coefficients of high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), and systolic blood pressure (BP) with height in parents, and in offspring according to Tanner stage healthy subjects. Populations at high risk of CHD might be more appropriate for detecting a familial clustering between height and risk factors of CHD, as suggested by the EARS study where correlations between LDL-C (or apoB) levels and height were stronger in individuals having a paternal history of CHD than in control subjects. 12 By contrast with LDL-C, the pattern of familial cross-trait correlations between height and HDL-C-with the correlation between biological relatives of similar magnitude to the spouse correlation-suggested that the clustering of these two traits was rather influenced by shared environmental factors. For triglycerides, the pattern was intermediate between LDL-C and HDL-C, with higher cross-trait correlations between biological relatives than between spouses, although the difference did not reach statistical significance. Actually, HDL-C and triglyceride levels are part of the cluster of risk factors defining the insulin resistance syndrome, or 'syndrome X', which is suspected to have a genetic basis but is also influenced by familial shared lifestyle factors. 21, 28 The relationship between height and BP levels appeared more complex, with an inversion of the correlation between childhood and adulthood, which was mainly observed in males, and no significant familial cross-trait correlation. It is widely admitted that the rise in BP during childhood closely relates to growth and sexual maturation. However, a meta-analysis of the systolic BP changes during childhood and adolescence showed that the positive correlation with age during childhood fell to 0 in boys and even reversed in girls at the end of puberty. 29 We found a similar reduction of the correlation between systolic BP and height between the pre-pubertal and the post-pubertal periods. A plausible interpretation for these findings might be that, as for lipids, a short stature would be associated with an adverse BP profile, as suggested in adults, but in children, this negative relationship would be masked by the massive effect of growth on BP levels.
The biological mechanisms underlying the association between height and CHD risk are unclear. It is beyond dispute that environmental factors, probably related to early nutrition, account for a substantial proportion of the variability of height in the population, as suggested in particular by the trends in height over the last decades. 30 While attained height is generally regarded as a reflection of early life experience, 31 the relationship between height and CHD is often assumed to arise from the same period. 11 That socioeconomic confounding is not the only explanation for such finding is attested by the association observed between height and cardiovascular disease in the socioeconomically homogeneous US population of male physicians. 5 The role of genetic factors in the height/CHD relationship has not yet been properly examined, even in twin studies which are often advocated for testing a genetic influence 32, 33 (see ref. 12 for a critical discussion). The hypothesis of a genetic contribution was, however, suggested by the results of the EARS study showing that height was an independent transmissible risk factor for CHD. 12 In accordance with the EARS findings, our results would be compatible with the hypothesis of a transmissible component in the relationship linking height to LDL-C.
Some limitations of the present study have to be discussed. First, the sample of families is probably not representative of the whole population of the region, depending on the bias that is associated with the participation in a free health check-up. It is likely that this sample is in healthier condition than the general population, and this is a second limitation of our study since, as mentioned above, a clustering of CHD risk factors would probably e Blood pressure.
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* P Ͻ 0.05; ** P Ͻ 0.01; *** P Ͻ 0.001. HEIGHT AND CARDIOVASCULAR RISK FACTORS 613 be easier to detect in high-risk populations. To which extent our findings would apply to older cohorts-with different birthweight and height distributions as well as larger family sizes-is also unknown. Finally, since several phenotypes were examined, we cannot exclude the fact that multiple testing resulted in some false positive results.
In conclusion, the present study suggests that transmissible factors might, at least partly, explain the relationship linking short stature to increased LDL-C levels. The hypothesis of a genetic contribution will have to be more formally tested by examining candidate gene polymorphisms. Genes belonging to the system of insulin-like growth factors (IGF) appear as strong candidates given their role in pre-and postnatal growth 34 as well as susceptibility to cardiovascular disease. [35] [36] [37] People of shorter height have increased risk of coronary heart disease (CHD). This was suggested by Gertler and White in 1954 and shown in the Whitehall Study 1 and in other populations. The mechanisms remain unclear. Height is determined by genetic and early environmental influences. Prenatal growth, as well as early postnatal growth, which is particularly vulnerable to environmental influences, have both been argued to be important for the association between height and cardiovascular risk factors and disease. People from poor socioeconomic environments are of shorter height; similarly they have increased levels of risk factors and subsequent CHD. 2 It has been suggested that genetic factors that influence growth also have a role in early programming of CHD, 3 and the relative contribution of genetic factors and poor socioeconomic environment is still unknown. A study that sets out to shed light on this question is therefore welcome.
In this issue of the International Journal of Epidemiology, La Batide-Alanore and her co-authors report one of the first studies attempting to disentangle genetic from shared environmental influences on the height-CHD association by examining coronary risk factors. 4 Using data from the STANISLAS study, height in each family member is correlated with cardiovascular risk factors in the other members, and correlations between biological relatives are compared with those between spouses. Their findings are compatible with a weak transmissible component for the association between height and low density lipoprotein (LDL)-cholesterol (correlation among relatives -0.04 and no correlation between spouses), while patterns for high density lipoprotein (HDL)-cholesterol and triglycerides seem to represent environmental, rather than genetic influences. No
